Schmelzeisen Rainer, Schimming Ronald, Sittinger Michael
Department of Oral and Craniomaxillofacial Surgery, University Hospital Freiburg, Freiburg, Germany.
J Craniomaxillofac Surg. 2003 Feb;31(1):34-9. doi: 10.1016/s1010-5182(02)00163-4.
Autologous, allogenic and alloplastic materials for bony reconstruction in the cranio-maxillofacial area have many drawbacks thus stimulating the on-going search for new (bio-)materials. Whereas cultivated skin and mucosa are already in clinical routine use in head and neck reconstruction, so far there has been no successful clinical application to the best of our knowledge of periosteum-derived, tissue-engineered bone for augmentation of the edentulous posterior maxilla. In a pilot study, augmentation of the posterior maxilla was carried out using a bone matrix derived from mandibular periosteal cells on a polymer fleece. This paper demonstrates fabrication of the matrix, clinical application, and the histological results in two patients. The results suggest that periosteum-derived osteoblasts on a suitable matrix form lamellar bone within 4 months which allows reliable implant insertion.
用于颅颌面区域骨重建的自体、异体和异种材料存在诸多缺点,因此促使人们不断寻找新的(生物)材料。尽管培养的皮肤和黏膜已在头颈部重建的临床常规中使用,但据我们所知,迄今为止,源自骨膜的组织工程骨用于无牙后上颌骨增量尚无成功的临床应用。在一项试点研究中,使用源自下颌骨膜细胞并置于聚合物纤维上的骨基质对上颌骨后部进行了增量。本文展示了该基质的制作、临床应用以及两名患者的组织学结果。结果表明,置于合适基质上的源自骨膜的成骨细胞在4个月内形成板层骨,这使得可靠地植入种植体成为可能。